Lowering the prophylactic platelet transfusion threshold: A prospective analysis

被引:48
|
作者
Lawrence, JB [1 ]
Yomtovian, RA [1 ]
Hammons, T [1 ]
Masarik, SR [1 ]
Chongkolwatana, V [1 ]
Creger, RJ [1 ]
Manka, A [1 ]
Lazarus, HM [1 ]
机构
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
platelet transfusion; hemorrhage; thrombocytopenia; leukemia; blood & marrow transplant;
D O I
10.3109/10428190109057955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The 20 x 10(9)/L threshold for prophylactic platelet transfusion may be unnecessarily high. Few prospective studies. however, in which other trigger values were tested have been published. In this study all hospitalized, thrombocytopenic adult hematology-oncology patients in our institution were prospectively evaluated daily for hemorrhage and platelet transfusion during a one year period; no patients were excluded for bleeding or infectious problems. By design, during the initial six-months: (baseline period), the prophylactic platelet transfusion trigger was 20 x 10(9)/L; for the second six-months (study period) this threshold was changed to 10 x 10(9)/L. Patients studied during the two periods did not differ significantly in age, gender. diagnosis. blood or marrow transplant status, and duration of neutropenia. Compliance with the thresholds was 95.6% (baseline period) and 93.5% (study period). For patients with platelet counts under 20 x 10(9)/L. the mean use of platelet transfusions per patient per day was significantly lower in the study period (4.47) than in the baseline period (6.48: p<0.001). Both mean prophylactic (1.54/patient-day) and therapeutic (2.93/patient-day) platelet transfusions were reduced in the study period compared with the baseline period (2.16 and 4.22/patient-day, respectively). Hemorrhage was slightly reduced in the study period compared with the baseline period: major hemorrhage, 15.2% vs. 18.4% (p=0.014): minor hemorrhage. 63.6% vs. 70.1% (p<0.001). Thus, hemorrhage was not increased with the lower trigger level. A 10 x 10(9)/L prophylactic platelet transfusion threshold value is safe and effective.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
  • [21] Prophylactic Platelet Transfusion: Is There Evidence of Benefit, Harm, or No Effect?
    Maier, Cheryl L.
    Stanworth, Simon J.
    Sola-Visner, Martha
    Kor, Daryl
    Mast, Allan E.
    Fasano, Ross
    Josephson, Cassandra D.
    Triulzi, Darrell J.
    Nellis, Marianne E.
    TRANSFUSION MEDICINE REVIEWS, 2023, 37 (04)
  • [22] HAEMATOLOGICAL CANCER Prophylactic platelet transfusion is frequently not necessary
    Schiffer, Charles A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) : 431 - 432
  • [23] Prophylactic platelet transfusion in dengue: Blanket of false comfort?
    Sharma, Ashish
    Ali, Mohammad
    NATIONAL MEDICAL JOURNAL OF INDIA, 2018, 31 (01): : 24 - 25
  • [24] The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies
    Akay, Olga Meltem
    Sahin, Deniz Goren
    Andic, Neslihan
    Gunduz, Eren
    Karagulle, Mustafa
    Colak, Ertugrul
    Gulbas, Zafer
    TRANSFUSION AND APHERESIS SCIENCE, 2015, 53 (01) : 64 - 68
  • [25] PROPHYLACTIC PLATELET TRANSFUSION IN ACUTE-LEUKEMIA - REPLY
    GMUR, J
    SCHAFFNER, A
    LANCET, 1992, 339 (8785): : 120 - 121
  • [26] Compliance with prophylactic platelet transfusion trigger in haematological patients
    Eikenboom, JCJ
    van Wordragen, R
    Brand, A
    TRANSFUSION MEDICINE, 2005, 15 (01) : 45 - 48
  • [28] Pro - Therapeutic and prophylactic platelet transfusion "less is more"
    Wandt, H.
    ONKOLOGIE, 2010, 33 : 16 - 17
  • [29] Time to stop prophylactic platelet transfusion for adult dengue
    Assir, Muhammad Zaman Khan
    LANCET, 2017, 389 (10079): : 1583 - 1584
  • [30] The Performance of Haematology Analyzers and the Platelet Transfusion Threshold
    Papa, F.
    Cedrone, M.
    Rongioletti, M.
    Fenu, S.
    Chierichini, A.
    Panetta, V.
    Pasqualetti, P.
    Lenti, L.
    Annino, L.
    Liumbruno, G. M.
    TRANSFUSION, 2009, 49 : 163A - 163A